Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.

Autor:	Boyko EJ; Veterans Affairs Puget Sound Health Care System, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Zelnick LR; Department of Medicine, University of Washington, Seattle, WA., Braffett BH; Biostatistics Center, George Washington University, Rockville, MD., Pop-Busui R; Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI., Cowie CC; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD., Lorenzi GM; University of California, San Diego, La Jolla, CA., Gubitosi-Klug R; Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH., Zinman B; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada., de Boer IH; Veterans Affairs Puget Sound Health Care System, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.
Jazyk:	angličtina
Zdroj:	Diabetes care [Diabetes Care] 2022 Feb 01; Vol. 45 (2), pp. 357-364.
DOI:	10.2337/dc21-1816
Abstrakt:	Objective: Intensive glycemic control reduces the risk of kidney, retinal, and neurologic complications in type 1 diabetes (T1D), but whether it reduces the risk of lower-extremity complications is unknown. We examined whether former intensive versus conventional glycemic control among Diabetes Control and Complications Trial (DCCT) participants with T1D reduced the long-term risk of diabetic foot ulcers (DFUs) and lower-extremity amputations (LEAs) in the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) study. Research Design and Methods: DCCT participants (n = 1,441) completed 6.5 years on average of intensive versus conventional diabetes treatment, after which 1,408 were enrolled in EDIC and followed annually over 23 years for DFU and LEA occurrences by physical examination. Multivariable Cox proportional hazard regression models estimated associations of DCCT treatment assignment and time-updated exposures with DFU or LEA. Results: Intensive versus conventional glycemic control was associated with a significant risk reduction for all DFUs (hazard ratio 0.77 [95% CI 0.60, 0.97]) and a similar magnitude but nonsignificant risk reduction for first-recorded DFUs (0.78 [0.59, 1.03]) and first LEAs (0.70 [0.36, 1.36]). In adjusted Cox models, clinical neuropathy, lower sural nerve conduction velocity, and cardiovascular autonomic neuropathy were associated with higher DFU risk; estimated glomerular filtration rate <60 mL/min/1.73 m2, albuminuria, and macular edema with higher LEA risk; and any retinopathy and greater time-weighted mean DCCT/EDIC HbA1c with higher risk of both outcomes (P < 0.05). Conclusions: Early intensive glycemic control decreases long-term DFU risk, the most important antecedent in the causal pathway to LEA. (© 2022 by the American Diabetes Association.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu